We also suggest that the moderate but significant enhancing effect of quercetin in inducing apoptosis when associated with anti-CD95, rTRAIL, and fludarabine (Figures 1 and 4) can be explained evoking the variability of B-CLL cells and the heterogeneity of the disease. The gene discussed is FAS; the disease is B-cell chronic lymphocytic leukemia.